32,561 results on '"Staphylococcus aureus"'
Search Results
2. Inner Mongolia Yili Industrial Group files patent for probiotic composition with human milk oligosaccharides
3. Concerto Biosciences Announces First Participant Dosed with Live Biotherapeutic ENS-002 in Phase 1 Trial for Atopic Dermatitis
4. Alphyn Biologics Announces Peer-Reviewed Paper Published in Journal of Drugs in Dermatology
5. Pathogen Transmission in Hospitals Puts Patients & Family Members at Risk; Xenex LightStrike+ Robots Proven to Destroy Deadly Germs on Hospital Surfaces
6. Charm Peel Plate SA (Staphylococcus aureus) Microbial Test Receives AOAC-RI PTM SM Approval
7. Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors
8. Milton Regional Sewer Authority Selects Burnham RNG to Transform Water Treatment Facility
9. Data on Listeria monocytogenes Reported by Hongzhou Chen and Colleagues (Development of dual polymerase spiral reaction for detection of Listeria monocytogenes and Staphylococcus aureus simultaneously).
10. Basilea Pharmaceutical International Ltd. Reports Findings in Staphylococcus aureus (Ceftobiprole activity against multidrug-resistant Staphylococcus aureus clinical isolates collected in the United States from 2016 through 2022).
11. Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera(R) ceftobiprole.
12. New Data from Janssen Research & Development Illuminate Research in Surgical Wound Infection (Postsurgical Carprofen Does Not Substantially Decrease Bacterial Growth in a Minipig Model of Staphylococcus aureus Deep Surgical Wound Infection).
13. Researchers Submit Patent Application, "Antibody For Hair Improvement Use", for Approval (USPTO 20240391983).
14. Phaxiam reports very high spectrum of activity its anti-S. aureus phages
15. Destiny Pharma launches research on XF-73 for cystic fibrosis MRSA infections
16. Destiny Pharma to present promising XF-73 data on MRSA at IPS conference
17. Becton Dickinson announces FDA clearance for BD Kiestra MRSA imaging application
18. Armata Pharmaceuticals Announces the Completion of Enrollment of its Phase 1b/2a diSArm Study Evaluating Intravenous AP-SA02 as a Potential Treatment for Staphylococcus aureus Bacteremia.
19. "Rigid Surface Treatment Agent" in Patent Application Approval Process (USPTO 20240349734).
20. Patent Issued for Pharmaceutical preparation and medical device (USPTO 12109233).
21. Researchers from AstraZeneca Detail New Studies and Findings in the Area of Gene Therapy (In Vivo Mrna Expression of a Multi-mechanistic Mab Combination Protects Against Staphylococcus Aureus Infection).
22. Infections of the Skin
23. Utility of multiplex real-time PCR for diagnosing paediatric acute respiratory tract infection in a tertiary care hospital
24. Patent Issued for Device and method for in vivo photoacoustic diagnosis and photothermal purging of infected blood (USPTO 12042248).
25. Patent Issued for Non-aqueous topical compositions comprising a halogenated salicylanilide (USPTO 12036312).
26. Researchers Submit Patent Application, "Method and Kit for Identifying Bacteria that Cause Sepsis", for Approval (USPTO 20240167103).
27. Sequence types 8, 59, and 45 methicillin resistant Staphylococcus aureus as the predominant strains causing skin and soft tissue infections in Taiwan's prisons and jails
28. ContraFect announces presentation data on exebacase
29. Methicillin Resistant Staphylococcus Aureus Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)
30. PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureus
31. Basilea reports new data for ceftobiprole (Zevtera(R)) presented at US IDWeek Congress 2023
32. PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains
33. Basilea announces FDA acceptance of New Drug Application for antibiotic ceftobiprole
34. Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus
35. Acurx Announces Presentation and Update of Its pol IIIC R&D Pipeline at the World Antimicrobial Resistance Scientific Congress
36. Genesis MedTech introduces China's first domestic brand of NPMA-approved antibacterial sutures
37. Hand eczema and temporal variation of Staphylococcus aureus clonal complexes: A prospective observational study
38. Clinical profile and microbiological aetiology diagnosis in adult patients hospitalized with community-acquired pneumonia
39. Septic arthritis of the temporomandibular joint in adults: Systematic review
40. ContraFect to Present at the World Anti-Microbial Resistance Congress 2023
41. Evaxion presents promising results on EVX-B1, an AI-designed vaccine against Staphylococcus aureus
42. CUROXEN Wound Ointment Eradicates Drug-Resistant Candida Auris
43. Felodipine enhances aminoglycosides efficacy against implant infections caused by methicillin-resistant Staphylococcus aureus, persisters and biofilms
44. Viability of hospital pathogens on mobile phone
45. Antibiotic resistance in neonates in China 2012–2019: A multicenter study
46. An in vitro study into the antimicrobial and cytotoxic effect of Acticoat™ dressings supplemented with chlorhexidine
47. First report on the prevalence of bacteria in cystic fibrosis patients (CF) in a tertiary care center in Saudi Arabia
48. Distribution of sasX, qacA/B and mupA genes and determination of genetic relatedness of methicillin-resistant Staphylococcus aureus among clinical isolates and nasal swab samples from the same patients in a hospital in Malaysia
49. Identification of microbes in wounds using near-infrared spectroscopy
50. Patent Issued for Bismuth-thiol compositions and methods for treating wounds (USPTO 11974978).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.